Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2019 $ 27,251 $ 57 $ 122,907 $ (95,579) $ (134)
Beginning balance, Shares at Dec. 31, 2019   11,314,150      
Exercise of stock options 57   57    
Exercise of stock options, Shares   17,543      
Issuance of common stock in connection with exercise of warrants, Shares   46,939      
Issuance of common stock from RSUs vested, Shares   20,297      
Stock-based compensation 887   887    
Other comprehensive income (loss) (227)       (227)
Net income (loss) 13     13  
Ending balance at Mar. 31, 2020 27,981 $ 57 123,851 (95,566) (361)
Ending balance, Shares at Mar. 31, 2020   11,398,929      
Beginning balance at Dec. 31, 2020 34,305 $ 58 128,771 (94,354) (170)
Beginning balance, Shares at Dec. 31, 2020   11,538,998      
Exercise of stock options $ 213   213    
Exercise of stock options, Shares 60,600 60,600      
Issuance of common stock in connection with exercise of warrants $ 8   8    
Issuance of common stock in connection with exercise of warrants, Shares   50,716      
Issuance of common stock from RSUs vested, Shares   24,332      
Issuance of common stock from ESPP purchase, Shares 0        
Repurchase of common stock $ (2,192)   (2,192)    
Repurchase of common stock, Shares (56,162) (56,162)      
Stock-based compensation $ 1,375   1,375    
Other comprehensive income (loss) (17)       (17)
Net income (loss) 79     79  
Ending balance at Mar. 31, 2021 $ 33,771 $ 58 $ 128,175 $ (94,275) $ (187)
Ending balance, Shares at Mar. 31, 2021   11,618,484